Myocardial Iodine-123-Metaiodobenzylguanidine (123i-Mibg) Imaging in Brugada Syndrome * Response

Circulation - United States
doi 10.1161/01.cir.0000031719.90222.e8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Future of Cardiac 123-I MIBG Imaging

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2016English

123i-Methyljodbenzylguanidin- (MIBG-) Szintigraphie

Der Pathologe
Forensic MedicinePathology
2007English

Chemical System for Delivering the Imaging Agent Metaiodobenzylguanidine (MIBG) to the CNS

Science-Business eXchange
2010English

Variations in 123i-Metaiodobenzylguanidine (MIBG) Late Heart Mediastinal Ratios in Chronic Heart Failure: A Need for Standardisation and Validation

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2007English

I-123-Mibg Cardiac Innervation Imaging in Patients With Atrial Fibrillation

Journal of Nuclear Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2019English

Prognostic Value of Iodine-123-Metaiodobenzylguanidine Imaging and Cardiac Natriuretic Peptide Levels in Patients With Left Ventricular Dysfunction Resulting From Cardiomyopathy

Japanese Circulation Journal
2001English

123i-Labeled Metaiodobenzylguanidine for Diagnosis of Neuroendocrine Tumors

Reports in Medical Imaging
Nuclear MedicineRadiologyImaging
2009English

The Utility of the Combined Use of 123i-Fp-Cit and 123i-Mibg Myocardial Scintigraphy in Differentiating Parkinson’s Disease From Other Parkinsonian Syndromes

Yonago Acta Medica
Medicine
2018English

123i-Mibg Scintigraphy and 18f-FDG PET in Neuroblastoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy